SCHEMBL5730188

SCHEMBL5730188

OCC1CCc2ccc3[nH]c(C(F)(F)F)nc3c2O1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 7/20 0.66
DRD3 P35462 7/20 0.66
DRD2 P14416 6/20 0.66
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
MEN1 O00255 2/20 0.36
GAA P10253 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PARP1 P09874 1/20 0.36
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
GNRHR P30968 2/20 0.33
GRM2 Q14416 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5729865 0.80 DRD2 (0.57) DRD4DRD3DRD2KDM4EHPGD
SCHEMBL5729832 0.78 DRD2 (0.54) DRD4DRD3DRD2KDM4EHPGD
SCHEMBL6864820 0.69 DRD4 (0.45) DRD4DRD3DRD2KDM4EHPGD
SCHEMBL5730420 0.69 DRD2 (0.63) DRD4DRD3DRD2NFKB1NFKB2
SCHEMBL6749348 0.65 NFKB1 (0.62) NFKB1NFKB2RELA
SCHEMBL5729792 0.64 NFKB1 (0.34) DRD4DRD3DRD2NFKB1NFKB2
SCHEMBL5729167 0.63 DRD2 (0.73) DRD4DRD3DRD2NFKB1NFKB2
SCHEMBL7110632 0.62 CHRM3 (0.40) DRD3DRD2HTR1AHTR1DHTR1B
SCHEMBL7110625 0.62 CHRM3 (0.40) DRD3DRD2HTR1AHTR1DHTR1B
SCHEMBL6864825 0.62 DRD2 (0.41) DRD4DRD3DRD2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409490-B1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA A|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY WYETH CORP (US) 2006-09-06 EP disclosed
EP-1421086-B1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY WYETH CORP (US) 2006-08-30 EP disclosed
EP-1421086-A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY Wyeth (US) 2004-05-26 EP disclosed
EP-1409490-A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA A]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY Wyeth (US) 2004-04-21 EP disclosed
US-6541501-B2 Dopamine autoreceptor agonists WYETH 2003-04-01 US disclosed
US-6541502-B1 Treatment of disorders associated with dopamine dysregulation such as schizophrenia WYETH 2003-04-01 US disclosed
US-20030037701-A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[A]-NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY WYETH 2003-02-27 US disclosed
WO-2003008420-A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[A]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY WYETH (US) 2003-01-30 WO disclosed
WO-2003008419-A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY WYETH (US) 2003-01-30 WO disclosed